𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of ursodeoxycholic acid and chenodeoxycholic acid on major histocompatibility complex class I gene expression

✍ Scribed by Fuminori Hirano; Hirotoshi Tanaka; Yuichi Makino; Kensaku Okamoto; Isao Marino


Publisher
Springer Japan
Year
1996
Tongue
English
Weight
1013 KB
Volume
31
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Hepatic expression of class I and class
✍ Yvon Calmus; Pierre Gane; Philippe Rouger; Raoul Poupon πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 410 KB

Aberrant hepatic expression of HLA molecules has been shown to be present in primary biliary cirrhosis and may play a determining role in the pathogenesis of the disease. We have studied the effect of the long-term administration of ursodeoxycholic acid on hepatic HLA expression. Nine untreated pati

Expression of class I and class II major
✍ Alessandra Franco; Vincenzo Barnaba; Piergiorgio Natali; Clara Balsano; Antonino πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 715 KB

We analyzed whether normal human hepatocytes, which normally do not display Class I1 major histocompatibility complex antigens, can be induced to express them in vitro, and whether this induction has an in vivo counterpart in chronic liver diseases. While both a-and y-interferon induced expression o

Cell type-specific regulation of major h
✍ Paul T. Massa; Keiko Ozato; Dale E. McFarlin πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 764 KB

Mechanisms of major histocompatibility complex (MHC) class I gene regulation in cells of the CNS have been studied in vitro. Astrocytes in primary cultures, but neither oligodendrocytes nor neurons, constitutively expressed cell surface MHC class I molecules. Interferon-gamma (IFN-.I) treatment led

The effect of photodynamic therapy on tu
✍ Alan Belicha-Villanueva; Jonah Riddell; Naveen Bangia; Sandra O. Gollnick πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 299 KB

## Abstract ## Background and Objective Photodynamic therapy (PDT) is FDA‐approved anti‐cancer modality for elimination of early disease and palliation in advanced disease. PDT efficacy depends in part on elicitation of a tumor‐specific immune response that is dependent on cytotoxic T lymphocytes